https://www.dana-farber.org/clinical-trials/21-007
B- PRISM (Precision Intervention Smoldering Myeloma): A Phase II Trial of Combination of...
The purpose of this research study is to learn whether the combination of daratumumab SC ( Darzalex Faspro), lenalidomide (Revlimid), bortezomib (Velcade) and...
phase ii trialsmoldering myeloma
https://www.dana-farber.org/clinical-trials/22-546
CAR-PRISM (PRecision Intervention Smoldering Myeloma): A Chimeric Antigen Receptor T cell (CAR-T)...
The goal of this research study is to test if ciltacabtagene autoleucel (cilta-cel) is safe and effective in treating participants with high-risk, smoldering...
chimeric antigen receptorsmoldering myeloma
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/smoldering-myeloma
Definition of smoldering myeloma - NCI Dictionary of Cancer Terms - NCI
NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine.
definition ofsmoldering myelomancidictionarycancer
https://www.hmpgloballearningnetwork.com/site/onc/videos/advances-patients-high-risk-smoldering-multiple-myeloma
Advances for Patients With High-Risk Smoldering Multiple Myeloma
Victor Jimenez Zepeda, MD, discusses the evolving management of patients with high-risk smoldering multiple myeloma. Multiple Myeloma Videos
for patientshigh riskadvancessmolderingmultiple
https://www.aacr.org/about-the-aacr/newsroom/news-releases/bcma-directed-car-t-cell-therapy-may-be-effective-against-high-risk-smoldering-multiple-myeloma/
BCMA-directed CAR T-cell Therapy May Be Effective Against High-risk Smoldering Multiple Myeloma |...
Apr 20, 2026 - All patients were negative for minimal residual disease, and no patients experienced progression to active multiple myeloma during the median 15.3 months of...
car t cell therapy
https://www.siemens-healthineers.com/es/plasma-protein/n-latex-flc-ratio
Early therapy in smoldering multiple myeloma: use of FLC ratio with N Latex FLC assays - Siemens...
Published clinical research studies the use of FLC ratio with N Latex FLC assays for patients with smoldering multiple myeloma
https://www.news-medical.net/news/20260420/Single-CAR-T-infusion-shows-strong-response-in-patients-with-high-risk-smoldering-multiple-myeloma.aspx
Single CAR T infusion shows strong response in smoldering multiple myeloma patients
Apr 21, 2026 - A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in patients with high-risk smoldering...
smoldering multiple myelomasingle car